Recombinant Human PTP4A3 Protein，His

PTP4A3, also known as protein tyrosine phosphatase 4A3, is a member of the PTP family, which plays a crucial role in regulating various cellular processes through dephosphorylation of tyrosine residues on target proteins. Its expression has been linked to several types of cancer, particularly in the context of cell proliferation, migration, and invasion. Overexpression of PTP4A3 has been associated with tumorigenesis and poor prognosis in various malignancies, making it a potential oncogenic factor. Researchers have focused on understanding the functional mechanisms of PTP4A3 in signaling pathways involved in cancer progression, including its interactions with other cellular proteins and its role in modifying the tumor microenvironment. The study of recombinant PTP4A3 proteins allows for the investigation of its enzymatic activity, regulatory mechanisms, and potential as a therapeutic target. By producing PTP4A3 in a controlled laboratory setting, scientists can conduct detailed biochemical assays and structural studies, paving the way for the development of inhibitors that specifically target PTP4A3's phosphatase activity. This research is critical for unlocking new avenues for cancer treatment and enhancing our understanding of the molecular underpinnings of oncogenesis. As such, PTP4A3 has emerged as an important focus in the field of cancer research, driving efforts to elucidate its role in tumor biology and therapeutic strategies.